(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride, 97%, 100mg

5-Hydroxy-4-methoxy-2-nitrobenzoic acid, 95.0%, 10g

Oxion Inverso OX.2053-PLPH-ICSI avec objectifs LWD Plan phase 10x/20x/40x, équipement ICSI et table croisée XY

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine, 98%, 500mg

Methyl 5-amino-1H-indazole-3-carboxylate hydrochloride, 96%, 100mg

2-Methylpyrazolo[1,5-a]pyridine-3-carboxylic acid, 95+%, 100mg

Gants de protection contre le froid Cryo-Gloves® imperméables avec manchette, longueur épaule, 685 mm, Taille, L (10), 1 paire

1-(2�-Hydroxylethyl)-3-methylimidazolium bis((trifluoromethyl)sulfonyl)imide, 97%, 25g

5-Bromo-2-methylbenzothiazole, 95.0%, 25g

tert-Butyl (5-bromopyridin-3-yl)carbamate, 95.0%, 100g

tert-butyl N-({1H,4H,5H,7H-pyrano[3,4-c]pyrazol-7-yl}methyl)carbamate, 97%, 500mg

3-Amino-N-tert-butyl-benzenesulfonamide, 95.0%, 10g

2-(Trifluoromethyl)phenylhydrazine hydrochloride, 98.0%, 25g